期刊文献+

建立用生色底物法研究重组水蛭素在大鼠血浆中的药动学 被引量:2

Determination of recombinant hirudin in plasma of rats by chromogenic substrate assay
原文传递
导出
摘要 目的:建立用生色底物法(chromogenic substrate assay,CSA)测定大鼠血浆中重组水蛭素(re-combinant hirudin,rH)含量的方法,并用该法研究rH在大鼠血浆中的药动学。方法:以TGPApNA(tosyl-gly-cyl-polyl-arginine-para-nitraniline)为底物,凝血酶(thrombin,Th)能水解TGPApNA释放出对-硝基苯胺(para-nitraniline,pNA),pNA在405nm处有特异性吸收,通过测定反应体系中未被rH中和的Th量,间接测定rH的活性。结果:CSA法能有效地测定大鼠血浆中rH的含量;rH的浓度在3.125~40 ng.mL-1范围内呈线性关系;日间和日内精密度相对标准偏差均符合要求。应用上述方法测定大鼠iv 2.0 mg.kg-1的rH后不同时间的血药浓度,结果表明该药符合二室模型一级动力学过程。结论:用生色底物法测定大鼠血浆中rH具有准确、可靠、重现性好的特点,可用于rH药动学的研究。 Objective: To develop a chromogenic substrate assay for determining the concentrations of the recombinant hirudin(rH) in plasma of rats.Methods: Because thrombin can specifically bind to rH and can hydrolyze chromogenic substrate(tosyl-glycyl-polyl-arginine-para-nitraniline) to release para-nitraniline with specific absorption at 405nm.Thus,it was used to detect the concentration of rH in plasma of rats.Results: The method could effectively and accurately detect the concentration of rH in plasma of rats.The linear range of rH was 3.125~40 ng·mL-1.The RSD of intra-day and inter-day was satisfactory.Applying the method,the concentration of the rH in plasma of rats was detected at different time points after iv 2.0 mg·kg-1.The results showed that the change in drug concentration met two-compartment model.Conclusion: Chromogenic substrate assay is an accurate and reproducible method and can be used in pharmacokinetic study to detect rH concentration in plasma of rats.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第4期372-375,共4页 Chinese Journal of New Drugs
基金 大连市科技计划项目(大连市科委2007E11SF059)
关键词 重组水蛭素 生色底物法 药动学 大鼠 recombinant hirudin chromogenic substrate assay(CSA) pharmacokinetic rat
  • 相关文献

参考文献7

二级参考文献23

  • 1任开环,韩国柱,李卫平,周琴.重组水蛭素抗大鼠冠状动脉血栓形成的作用研究[J].医药导报,2005,24(5):369-372. 被引量:5
  • 2毛平,陈蕃,李翠贞,黄润永,蔡小燕,关明媚.凝血酶法测定血浆肝素含量及其临床应用[J].中华医学检验杂志,1995,18(5):295-298. 被引量:5
  • 3尹宝光.水蛭对实验性脑水肿及皮下血肿的影响[J].中西医结合杂志,1986,7:407-407.
  • 4黄泰康.常用中药成分与管理手册[M].北京:中国医药科技出版社,1994.595-600.
  • 5胡玉清 赵中杰 等.9种虫类药物中28种元素的分析[J].中国药学杂志,1989,24(11):650-650.
  • 6MoW SongHY.Research advance on clinical application of recombinant hirudin [J].国外医学:药学分册,2004,31(2):82-86.
  • 7Iyer L. Koza M, Iqbal O, et al. Studies on the pharmacokinetics and pharmacyodynamics of recombinant hirudin (rHV2-1ys47) after intravenous and subcutaneous administration in dogs [J]. Tkromb Res, 1993, 69: 256-269.
  • 8Meiring S M, Lotter M G, Badenhorst P N, et al. Sites of elimination and pharmacokinetics of recombinant [1311] lepirudin in baboons [J]. J Pharm Sci, 1999, 88(5): 523-529.
  • 9LiuXW SongHF TangZM etal.Pharmacokinetics and partial thromboplastin time after intravenous recombinant hirudin variant—2 in rhesus monkeys[J].药学学报,2002,23(9):842-846.
  • 10JiangSY LiGX HanGZ.Study on pharmacokinetics of novel recombinant hirudin by ELISA in rats[J].中国药学杂志,2002,37(7):556-557.

共引文献53

同被引文献53

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部